ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Poliovirus Vaccine Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-1F745
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Poliovirus Vaccine Market Professional Survey Report 2019
BUY CHAPTERS

Global Poliovirus Vaccine Market Research Report 2024

Code: QYRE-Auto-1F745
Report
January 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
GSK
Bibcol
Serum Institute
Tiantan biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

Poliovirus Vaccine Market Size

The global Poliovirus Vaccine market was valued at US$ 709.8 million in 2023 and is anticipated to reach US$ 955.4 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.

Poliovirus Vaccine Market

Poliovirus Vaccine Market

Polio vaccines are vaccines used to prevent poliomyelitis (polio).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Poliovirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poliovirus Vaccine.

Report Scope

The Poliovirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Poliovirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Poliovirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Poliovirus Vaccine Market Report

Report Metric Details
Report Name Poliovirus Vaccine Market
Accounted market size in 2023 US$ 709.8 million
Forecasted market size in 2030 US$ 955.4 million
CAGR 4.4%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Inactivated Polio Vaccine (IPV)
  • Oral Polio Vaccine (OPV)
Segment by Application
  • Public
  • Private
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Poliovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Poliovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Poliovirus Vaccine Market growing?

Ans: The Poliovirus Vaccine Market witnessing a CAGR of 4.4% during the forecast period 2024-2030.

What is the Poliovirus Vaccine Market size in 2030?

Ans: The Poliovirus Vaccine Market size in 2030 will be US$ 955.4 million.

Who are the main players in the Poliovirus Vaccine Market report?

Ans: The main players in the Poliovirus Vaccine Market are Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals

What are the Application segmentation covered in the Poliovirus Vaccine Market report?

Ans: The Applications covered in the Poliovirus Vaccine Market report are Public, Private

What are the Type segmentation covered in the Poliovirus Vaccine Market report?

Ans: The Types covered in the Poliovirus Vaccine Market report are Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV)

1 Poliovirus Vaccine Market Overview
1.1 Product Overview and Scope of Poliovirus Vaccine
1.2 Poliovirus Vaccine Segment by Type
1.2.1 Global Poliovirus Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Poliovirus Vaccine Segment by Application
1.3.1 Global Poliovirus Vaccine Market Value by Application: (2024-2030)
1.3.2 Public
1.3.3 Private
1.4 Global Poliovirus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Poliovirus Vaccine Revenue 2019-2030
1.4.2 Global Poliovirus Vaccine Sales 2019-2030
1.4.3 Global Poliovirus Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Poliovirus Vaccine Market Competition by Manufacturers
2.1 Global Poliovirus Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Poliovirus Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Poliovirus Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Poliovirus Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Poliovirus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Poliovirus Vaccine, Product Type & Application
2.7 Poliovirus Vaccine Market Competitive Situation and Trends
2.7.1 Poliovirus Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Poliovirus Vaccine Players Market Share by Revenue
2.7.3 Global Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Poliovirus Vaccine Retrospective Market Scenario by Region
3.1 Global Poliovirus Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Poliovirus Vaccine Global Poliovirus Vaccine Sales by Region: 2019-2030
3.2.1 Global Poliovirus Vaccine Sales by Region: 2019-2024
3.2.2 Global Poliovirus Vaccine Sales by Region: 2025-2030
3.3 Global Poliovirus Vaccine Global Poliovirus Vaccine Revenue by Region: 2019-2030
3.3.1 Global Poliovirus Vaccine Revenue by Region: 2019-2024
3.3.2 Global Poliovirus Vaccine Revenue by Region: 2025-2030
3.4 North America Poliovirus Vaccine Market Facts & Figures by Country
3.4.1 North America Poliovirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Poliovirus Vaccine Sales by Country (2019-2030)
3.4.3 North America Poliovirus Vaccine Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Poliovirus Vaccine Market Facts & Figures by Country
3.5.1 Europe Poliovirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Poliovirus Vaccine Sales by Country (2019-2030)
3.5.3 Europe Poliovirus Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Poliovirus Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Poliovirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Poliovirus Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Poliovirus Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Poliovirus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Poliovirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Poliovirus Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Poliovirus Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Poliovirus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Poliovirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Poliovirus Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Poliovirus Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Poliovirus Vaccine Sales by Type (2019-2030)
4.1.1 Global Poliovirus Vaccine Sales by Type (2019-2024)
4.1.2 Global Poliovirus Vaccine Sales by Type (2025-2030)
4.1.3 Global Poliovirus Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Poliovirus Vaccine Revenue by Type (2019-2030)
4.2.1 Global Poliovirus Vaccine Revenue by Type (2019-2024)
4.2.2 Global Poliovirus Vaccine Revenue by Type (2025-2030)
4.2.3 Global Poliovirus Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Poliovirus Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Poliovirus Vaccine Sales by Application (2019-2030)
5.1.1 Global Poliovirus Vaccine Sales by Application (2019-2024)
5.1.2 Global Poliovirus Vaccine Sales by Application (2025-2030)
5.1.3 Global Poliovirus Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Poliovirus Vaccine Revenue by Application (2019-2030)
5.2.1 Global Poliovirus Vaccine Revenue by Application (2019-2024)
5.2.2 Global Poliovirus Vaccine Revenue by Application (2025-2030)
5.2.3 Global Poliovirus Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Poliovirus Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Poliovirus Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Poliovirus Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bibcol
6.3.1 Bibcol Corporation Information
6.3.2 Bibcol Description and Business Overview
6.3.3 Bibcol Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bibcol Poliovirus Vaccine Product Portfolio
6.3.5 Bibcol Recent Developments/Updates
6.4 Serum Institute
6.4.1 Serum Institute Corporation Information
6.4.2 Serum Institute Description and Business Overview
6.4.3 Serum Institute Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Serum Institute Poliovirus Vaccine Product Portfolio
6.4.5 Serum Institute Recent Developments/Updates
6.5 Tiantan Biological
6.5.1 Tiantan Biological Corporation Information
6.5.2 Tiantan Biological Description and Business Overview
6.5.3 Tiantan Biological Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tiantan Biological Poliovirus Vaccine Product Portfolio
6.5.5 Tiantan Biological Recent Developments/Updates
6.6 IMBCA
6.6.1 IMBCA Corporation Information
6.6.2 IMBCA Description and Business Overview
6.6.3 IMBCA Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 IMBCA Poliovirus Vaccine Product Portfolio
6.6.5 IMBCA Recent Developments/Updates
6.7 Panacea Biotec Ltd
6.6.1 Panacea Biotec Ltd Corporation Information
6.6.2 Panacea Biotec Ltd Description and Business Overview
6.6.3 Panacea Biotec Ltd Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Panacea Biotec Ltd Poliovirus Vaccine Product Portfolio
6.7.5 Panacea Biotec Ltd Recent Developments/Updates
6.8 Bio-Med
6.8.1 Bio-Med Corporation Information
6.8.2 Bio-Med Description and Business Overview
6.8.3 Bio-Med Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bio-Med Poliovirus Vaccine Product Portfolio
6.8.5 Bio-Med Recent Developments/Updates
6.9 Halfkin Bio-Pharmaceuticals
6.9.1 Halfkin Bio-Pharmaceuticals Corporation Information
6.9.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
6.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Portfolio
6.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Poliovirus Vaccine Industry Chain Analysis
7.2 Poliovirus Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Poliovirus Vaccine Production Mode & Process
7.4 Poliovirus Vaccine Sales and Marketing
7.4.1 Poliovirus Vaccine Sales Channels
7.4.2 Poliovirus Vaccine Distributors
7.5 Poliovirus Vaccine Customers
8 Poliovirus Vaccine Market Dynamics
8.1 Poliovirus Vaccine Industry Trends
8.2 Poliovirus Vaccine Market Drivers
8.3 Poliovirus Vaccine Market Challenges
8.4 Poliovirus Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
GSK
Bibcol
Serum Institute
Tiantan biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
List of Tables
    Table 1. Global Poliovirus Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Poliovirus Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Poliovirus Vaccine Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Poliovirus Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Poliovirus Vaccine Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Poliovirus Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Poliovirus Vaccine Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Poliovirus Vaccine Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Poliovirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Poliovirus Vaccine, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Poliovirus Vaccine, Product Type & Application
    Table 12. Global Key Manufacturers of Poliovirus Vaccine, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Poliovirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliovirus Vaccine as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Poliovirus Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Poliovirus Vaccine Sales by Region (2019-2024) & (K Units)
    Table 18. Global Poliovirus Vaccine Sales Market Share by Region (2019-2024)
    Table 19. Global Poliovirus Vaccine Sales by Region (2025-2030) & (K Units)
    Table 20. Global Poliovirus Vaccine Sales Market Share by Region (2025-2030)
    Table 21. Global Poliovirus Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Poliovirus Vaccine Revenue Market Share by Region (2019-2024)
    Table 23. Global Poliovirus Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Poliovirus Vaccine Revenue Market Share by Region (2025-2030)
    Table 25. North America Poliovirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Poliovirus Vaccine Sales by Country (2019-2024) & (K Units)
    Table 27. North America Poliovirus Vaccine Sales by Country (2025-2030) & (K Units)
    Table 28. North America Poliovirus Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Poliovirus Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Poliovirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Poliovirus Vaccine Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Poliovirus Vaccine Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Poliovirus Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Poliovirus Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Poliovirus Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Poliovirus Vaccine Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Poliovirus Vaccine Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Poliovirus Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Poliovirus Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Poliovirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Poliovirus Vaccine Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Poliovirus Vaccine Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Poliovirus Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Poliovirus Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Poliovirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Poliovirus Vaccine Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Poliovirus Vaccine Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Poliovirus Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Poliovirus Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Poliovirus Vaccine Sales (K Units) by Type (2019-2024)
    Table 51. Global Poliovirus Vaccine Sales (K Units) by Type (2025-2030)
    Table 52. Global Poliovirus Vaccine Sales Market Share by Type (2019-2024)
    Table 53. Global Poliovirus Vaccine Sales Market Share by Type (2025-2030)
    Table 54. Global Poliovirus Vaccine Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Poliovirus Vaccine Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Poliovirus Vaccine Revenue Market Share by Type (2019-2024)
    Table 57. Global Poliovirus Vaccine Revenue Market Share by Type (2025-2030)
    Table 58. Global Poliovirus Vaccine Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Poliovirus Vaccine Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Poliovirus Vaccine Sales (K Units) by Application (2019-2024)
    Table 61. Global Poliovirus Vaccine Sales (K Units) by Application (2025-2030)
    Table 62. Global Poliovirus Vaccine Sales Market Share by Application (2019-2024)
    Table 63. Global Poliovirus Vaccine Sales Market Share by Application (2025-2030)
    Table 64. Global Poliovirus Vaccine Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Poliovirus Vaccine Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Poliovirus Vaccine Revenue Market Share by Application (2019-2024)
    Table 67. Global Poliovirus Vaccine Revenue Market Share by Application (2025-2030)
    Table 68. Global Poliovirus Vaccine Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Poliovirus Vaccine Price (USD/Unit) by Application (2025-2030)
    Table 70. Sanofi Corporation Information
    Table 71. Sanofi Description and Business Overview
    Table 72. Sanofi Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Sanofi Poliovirus Vaccine Product
    Table 74. Sanofi Recent Developments/Updates
    Table 75. GSK Corporation Information
    Table 76. GSK Description and Business Overview
    Table 77. GSK Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. GSK Poliovirus Vaccine Product
    Table 79. GSK Recent Developments/Updates
    Table 80. Bibcol Corporation Information
    Table 81. Bibcol Description and Business Overview
    Table 82. Bibcol Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Bibcol Poliovirus Vaccine Product
    Table 84. Bibcol Recent Developments/Updates
    Table 85. Serum Institute Corporation Information
    Table 86. Serum Institute Description and Business Overview
    Table 87. Serum Institute Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Serum Institute Poliovirus Vaccine Product
    Table 89. Serum Institute Recent Developments/Updates
    Table 90. Tiantan Biological Corporation Information
    Table 91. Tiantan Biological Description and Business Overview
    Table 92. Tiantan Biological Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Tiantan Biological Poliovirus Vaccine Product
    Table 94. Tiantan Biological Recent Developments/Updates
    Table 95. IMBCA Corporation Information
    Table 96. IMBCA Description and Business Overview
    Table 97. IMBCA Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. IMBCA Poliovirus Vaccine Product
    Table 99. IMBCA Recent Developments/Updates
    Table 100. Panacea Biotec Ltd Corporation Information
    Table 101. Panacea Biotec Ltd Description and Business Overview
    Table 102. Panacea Biotec Ltd Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Panacea Biotec Ltd Poliovirus Vaccine Product
    Table 104. Panacea Biotec Ltd Recent Developments/Updates
    Table 105. Bio-Med Corporation Information
    Table 106. Bio-Med Description and Business Overview
    Table 107. Bio-Med Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Bio-Med Poliovirus Vaccine Product
    Table 109. Bio-Med Recent Developments/Updates
    Table 110. Halfkin Bio-Pharmaceuticals Corporation Information
    Table 111. Halfkin Bio-Pharmaceuticals Description and Business Overview
    Table 112. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product
    Table 114. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
    Table 115. Key Raw Materials Lists
    Table 116. Raw Materials Key Suppliers Lists
    Table 117. Poliovirus Vaccine Distributors List
    Table 118. Poliovirus Vaccine Customers List
    Table 119. Poliovirus Vaccine Market Trends
    Table 120. Poliovirus Vaccine Market Drivers
    Table 121. Poliovirus Vaccine Market Challenges
    Table 122. Poliovirus Vaccine Market Restraints
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Poliovirus Vaccine
    Figure 2. Global Poliovirus Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Poliovirus Vaccine Market Share by Type in 2023 & 2030
    Figure 4. Inactivated Polio Vaccine (IPV) Product Picture
    Figure 5. Oral Polio Vaccine (OPV) Product Picture
    Figure 6. Global Poliovirus Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Poliovirus Vaccine Market Share by Application in 2023 & 2030
    Figure 8. Public
    Figure 9. Private
    Figure 10. Global Poliovirus Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Poliovirus Vaccine Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Poliovirus Vaccine Sales (2019-2030) & (K Units)
    Figure 13. Global Poliovirus Vaccine Average Price (USD/Unit) & (2019-2030)
    Figure 14. Poliovirus Vaccine Report Years Considered
    Figure 15. Poliovirus Vaccine Sales Share by Manufacturers in 2023
    Figure 16. Global Poliovirus Vaccine Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Poliovirus Vaccine Players: Market Share by Revenue in 2023
    Figure 18. Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Poliovirus Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Poliovirus Vaccine Sales Market Share by Country (2019-2030)
    Figure 21. North America Poliovirus Vaccine Revenue Market Share by Country (2019-2030)
    Figure 22. the United States Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Poliovirus Vaccine Sales Market Share by Country (2019-2030)
    Figure 25. Europe Poliovirus Vaccine Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. UK Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Poliovirus Vaccine Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Poliovirus Vaccine Revenue Market Share by Region (2019-2030)
    Figure 33. China Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. China Taiwan Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Indonesia Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Thailand Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Malaysia Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Latin America Poliovirus Vaccine Sales Market Share by Country (2019-2030)
    Figure 43. Latin America Poliovirus Vaccine Revenue Market Share by Country (2019-2030)
    Figure 44. Mexico Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Brazil Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Argentina Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Poliovirus Vaccine Sales Market Share by Country (2019-2030)
    Figure 48. Middle East & Africa Poliovirus Vaccine Revenue Market Share by Country (2019-2030)
    Figure 49. Turkey Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Saudi Arabia Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. UAE Poliovirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Global Sales Market Share of Poliovirus Vaccine by Type (2019-2030)
    Figure 53. Global Revenue Market Share of Poliovirus Vaccine by Type (2019-2030)
    Figure 54. Global Poliovirus Vaccine Price (USD/Unit) by Type (2019-2030)
    Figure 55. Global Sales Market Share of Poliovirus Vaccine by Application (2019-2030)
    Figure 56. Global Revenue Market Share of Poliovirus Vaccine by Application (2019-2030)
    Figure 57. Global Poliovirus Vaccine Price (USD/Unit) by Application (2019-2030)
    Figure 58. Poliovirus Vaccine Value Chain
    Figure 59. Poliovirus Vaccine Production Process
    Figure 60. Channels of Distribution (Direct Vs Distribution)
    Figure 61. Distributors Profiles
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions